Expression of ezrin correlates with poor prognosis of nasopharyngeal carcinoma

Tumor Biology

Volumn 32, Issue 4, 2011, Pages 707-712

  Wang, Liang ^a   Lin, Gui Nan ^a   Jiang, Xiang Li ^a   Lu, Yue ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Ezrin; Nasopharyngeal carcinoma; Overall survival; Prognosis; Time to progression

Indexed keywords

CISPLATIN; EZRIN; FLUOROURACIL; IMMUNOGLOBULIN A ANTIBODY; VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX; SURVIVAL TIME; TIME TO PROGRESSION; VIRUS LOAD;

EID: 80052336839     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0171-8     Document Type: Article

References (22)

1. Chang ET, Adami H. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15 (10):1765-77. (Pubitemid 44664247)
2. Hiscox S, Jiang WG, et al. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci. 1999;112:3081-90. (Pubitemid 29465726)
3. Mc Clatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development. Nat Rev Cancer. 2003;3:877-83. (Pubitemid 37376984)
4. Vaheri A, Carpen O, Heiska L, et al. The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr Opin Cell Biol. 1997;9:659-66. (Pubitemid 27424922)
5. Ilmonen S, Vaheri A, Asko-Seljävaara S, et al. Ezrin in primary cutaneous melanoma. Mod Pathol. 2005;18:503-10. (Pubitemid 40478113)
6. Xie J-J, Xu L-Y, Xie Y-M, et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer. 2009;124:2549-58.
7. Elzagheid A, Korkeila E, Riyad, et al. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol. 2008;39:1737-43.
8. Mäkitie T, Carpen O, Vaheri A, et al. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci. 2001;42:2442-9. (Pubitemid 32954846)
9. Wang L, Gao Y, Tu Q, et al. Expression of ezrin and E-cadherin in nasopharyngeal carcinoma and its significance. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35(9):969-75.
10. Böhling T, Turunen O, Jääskeläinen J, et al. Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. Am J Pathol. 1996;148:367-73. (Pubitemid 26056721)
11. Ogino W, Takeshima Y, Mori T, et al. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis. J Pediatr Hematol Oncol. 2007;7:435-9. (Pubitemid 47026243)
12. Andy J. Minn, Joan Massague, Invasion and metastasis. In: Devita, Hellman & Rosenberg's Cancer: principles & practice of oncology, 8th ed. Philadelphia: Lippincott-Raven; 2008. p. 118-133
13. Takeuchi K, Sato N, Kasahara H, et al. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol. 1994;125:1371-84. (Pubitemid 24189539)
14. Liotta LA, Tryggvason K, Garbisa S, et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67-8. (Pubitemid 10098769)
15. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182-6. (Pubitemid 38524889)
16. Wan X, Mendoza A, Khanna C, et al. Rapamycin inhibits ezrinmediated metastatic behavior in a murine model of osteosarcoma. Cancer Res. 2005;65:2406-11. (Pubitemid 40490152)
17. Sarrió D, Rodríguez-Pinilla SM, et al. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat. 2006;1:71-9. (Pubitemid 44050782)
18. Ferrari S, Zanella L, et al. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Pediatr Blood Cancer. 2008;50:752-6. (Pubitemid 351354778)
19. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: Integrators at the cell cortex. Nat Rev Mol Cell Biol. 2002;3:586-99.
20. Endo K, Kondo S, Shackleford J, et al. Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene. 2009;28:1725-35.
21. Madan R, Brandwein-Gensler M, et al. Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck. 2006;11:1018-27. (Pubitemid 44630942)
22. Liu SJ, Sun YM, Tian DF, et al. Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Br J Cancer. 2008;98:363-9. (Pubitemid 351161254)